Repression of 5-aminolevulinate synthase gene by the potent tumor promoter, TPA, involves multiple signal transduction pathways
Related Experiment Video
Updated: Aug 18, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Alejandra S Guberman1, María E Scassa, Eduardo T Cánepa
1Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Pabellón II Piso 4, Ciudad Universitaria, 1428 Buenos Aires, Argentina.
Abstract:
The potent tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA) induces activator protein-1 (AP-1) transcription factors, early response genes involved in a diverse set of transcriptional regulatory processes, and protein kinase C (PKC) activity. This work was designed to explore the signal transduction pathways involved in TPA regulation of 5-aminolevulinate synthase (ALAS) gene expression, the mitochondrial matrix enzyme that catalyzes the first and rate-limiting step of heme biosynthesis. We have previously reported that TPA causes repression of ALAS gene, but the signaling pathways mediating this effect remain elusive. The present study investigates the role of different cascades often implicated in the propagation of phorbol ester signaling. To explore this, we combined the transient overexpression of regulatory proteins involved in these pathways and the use of small cell permeant inhibitors in human hepatoma HepG2 cells. In these experimental conditions, we analyzed TPA action upon endogenous ALAS mRNA levels, as well as the promoter activity of a fusion reporter construct, harboring the TPA-responsive region of ALAS gene driving chloramphenicol acetyl transferase gene expression. We demonstrated that the participation of alpha isoform of PKC, phosphatidylinositol 3-kinase (PI3K), extracellular-signal regulated kinase (ERK1/2), and c-Jun N-terminal kinase (JNK) is crucial for the end point response. Remarkably, in this case, ERK activation is achieved in a Ras/Raf/MEK-independent manner. We also propose that p90RSK would be a convergent point between PI3K and ERK pathways. Furthermore, we elucidated the crosstalk among the components of the cascades taking part in TPA-mediated ALAS repression. Finally, by overexpression of a constitutively active p90RSK and the coactivator, cAMP-response element protein (CREB)-binding protein (CBP), we reinforced our previous model, that implies competition between AP-1 and CREB for CBP.
Insights
12-O-tetradecanoylphorbol-13-acetate (TPA) represses 5-aminolevulinate synthase (ALAS) gene expression through protein kinase C (PKC), PI3K, ERK, and JNK signaling pathways. These pathways converge on p90RSK, highlighting crosstalk in TPA-mediated ALAS repression.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- 12-O-tetradecanoylphorbol-13-acetate (TPA) is a potent tumor promoter that activates transcription factors like AP-1 and protein kinase C (PKC).
- TPA is known to repress 5-aminolevulinate synthase (ALAS) gene expression, a key enzyme in heme biosynthesis, but the underlying signaling pathways remain unclear.
- Understanding these pathways is crucial for comprehending TPA's biological effects and potential therapeutic interventions.
Purpose of the Study:
- To elucidate the specific signal transduction pathways mediating TPA-induced repression of ALAS gene expression.
- To investigate the roles of various signaling cascades, including PKC, PI3K, ERK, and JNK, in TPA's regulation of ALAS.
- To explore the crosstalk and convergence points among these pathways.
Main Methods:
- Utilized human hepatoma HepG2 cells for experiments.
- Employed transient overexpression of regulatory proteins and small molecule inhibitors to probe signaling pathways.
- Analyzed endogenous ALAS mRNA levels and the activity of a reporter construct containing the ALAS promoter region.
Main Results:
- Demonstrated the crucial involvement of PKCalpha, phosphatidylinositol 3-kinase (PI3K), extracellular-signal regulated kinase (ERK1/2), and c-Jun N-terminal kinase (JNK) in TPA's effect on ALAS.
- Showed that ERK activation by TPA occurs independently of the Ras/Raf/MEK pathway.
- Identified p90RSK as a potential convergence point for PI3K and ERK signaling and elucidated crosstalk among the involved cascades.
Conclusions:
- The repression of ALAS gene expression by TPA is mediated by a complex network involving PKC, PI3K, ERK, and JNK signaling.
- p90RSK acts as a key convergent node in these pathways.
- The findings support a model of competition between AP-1 and CREB for CBP, influencing TPA-mediated ALAS repression.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
MAPK Signaling Cascades
Amplifying Signals via Enzymatic Cascade
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)